Literature DB >> 4149660

Letter: The effect of cannabidiol on maximal electroshock seizures in rats.

I Izquierdo, M Tannhauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4149660     DOI： 10.1111/j.2042-7158.1973.tb09976.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  10 in total

1.  Marijuana use and the risk of new onset seizures.

Authors:  J C Brust; S K Ng; A W Hauser; M Susser
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 2.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

3.  The pharmacological effect of fractions obtained by smoking cannabis through a water-pipe. II. A second fractionation step.

Authors:  H Lazaratou; A Moschovakis; A Armaganidis; V Kapsambelis; J Kiburis; T A Kephalas
Journal:  Experientia       Date:  1980-12-15

4.  Anticonvulsant action of cannabis in the rat: role of brain monoamines.

Authors:  P Ghosh; S K Bhattacharya
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

5.  Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.

Authors:  T U Järbe; B G Henriksson
Journal:  Psychopharmacologia       Date:  1974

6.  Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

Authors:  Brenda E Porter; Catherine Jacobson
Journal:  Epilepsy Behav       Date:  2013-12       Impact factor: 2.937

7.  Anticonvulsant activity of cyclopentano amino acids.

Authors:  R Zand; I Izquierdo
Journal:  Neurochem Res       Date:  1980-01       Impact factor: 3.996

Review 8.  Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.

Authors:  Krithiga Sekar; Alison Pack
Journal:  F1000Res       Date:  2019-02-28

9.  Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.

Authors:  Libor Uttl; Tomáš Hložek; Pavel Mareš; Tomáš Páleníček; Hana Kubová
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

10.  A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome.

Authors:  Bláthnaid McCoy; Laura Wang; Maria Zak; Sameer Al-Mehmadi; Nadia Kabir; Kenda Alhadid; Kyla McDonald; Grace Zhang; Rohit Sharma; Robyn Whitney; Katia Sinopoli; O Carter Snead
Journal:  Ann Clin Transl Neurol       Date:  2018-08-01       Impact factor: 4.511
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.